Form D · Biotechnology

Simcha Therapeutics Holding Company, LLC

New Haven, CT · CIK 0001746685

Offering snapshot reported Jun 20, 2025 · SEC filing

Reported sold
$7.11M
Offering amount: $10M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 13, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 20, 2025Initial$7,110,934No comparison5SEC filing
Sep 7, 2021Initial$39,999,995No comparison14SEC filing
May 21, 2020Initial$16,629,480No comparison14SEC filing
Jul 16, 2018Initial$4,400,534No comparison9SEC filing

Offering details

Securities
Debt, Option to acquire, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-549431
Convertible Promissory Notes

Source: Form D, filed Jun 20, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jake Bauer Director, Executive
Joseph Catino Executive
Gu Cuiping Director
Simeon George Director
Axel Hoos Director
Lennart H. Lee Director
Yiming Li Director
Beatrice Mc Queen Executive
Sanuj Ravindran Director, Executive
Aaron Ring Director, Executive
Terry Rosen Director
Richard Soll Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
157 Church Street 19th Floor
New Haven, CT, 06510